Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study

Annals of Gastroenterology ◽

10.20524/aog.2017.0136 ◽

2017 ◽

Cited By ~ 2

Author(s):

Alessandra Mangia

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Observational Study ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real World ◽

Safety Profile ◽

Efficacy And Safety ◽

The Real ◽

Peginterferon Alfa

Download Full-text

Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease

European Journal of Gastroenterology & Hepatology ◽

10.1097/meg.0000000000000121 ◽

2014 ◽

Vol 26 (8) ◽

pp. 836-845 ◽

Cited By ~ 20

Author(s):

Benjamin Maasoumy ◽

Kerstin Port ◽

Katja Deterding ◽

Christoph Höner zu Siederdissen ◽

Antoaneta A. Markova ◽

...

Keyword(s):

Chronic Hepatitis ◽

Liver Disease ◽

Hepatitis C ◽

Protease Inhibitor ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real World ◽

Safety Profile ◽

Advanced Liver Disease ◽

Limited Effectiveness

Download Full-text

The Real-World Efficacy and Safety of Direct-Acting Oral Antiviral Treatment in Chronic Hepatitis C Genotype 1 Patients in Turkey

Cumhuriyet Medical Journal ◽

10.7197/223.vi.376221 ◽

2018 ◽

pp. 768-776 ◽

Cited By ~ 1

Author(s):

Erol ÇAKMAK

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Antiviral Treatment ◽

Efficacy And Safety ◽

Genotype 1 ◽

The Real ◽

Direct Acting

Download Full-text

Faculty Opinions recommendation of Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718874849.793500002 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Safety Profile

Download Full-text

Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Om-bitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience

The Turkish Journal of Gastroenterology ◽

10.5152/tjg.2020.20696 ◽

2021 ◽

Vol 31 (12) ◽

pp. 883-893

Author(s):

Bulent Degertekin ◽

◽

Mehmet Demir ◽

Ulus S. Akarca ◽

Haluk Tarik Kani ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Efficacy And Safety ◽

Combination Therapies

Download Full-text

THU-124-Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)

Journal of Hepatology ◽

10.1016/s0618-8278(19)30399-8 ◽

2019 ◽

Vol 70 (1) ◽

pp. e213-e214

Author(s):

Marc Puigvehí ◽

Agustin Albillos ◽

Ana Viu ◽

Manuel Hernandez-Guerra ◽

Inmaculada Fernández Vázquez ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Drug Users ◽

Intravenous Drug ◽

Intravenous Drug Users ◽

Efficacy And Safety

Download Full-text

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

Liver International ◽

10.1111/liv.12300 ◽

2013 ◽

Vol 34 (5) ◽

pp. 707-719 ◽

Cited By ~ 12

Author(s):

Michael P. Manns ◽

Jonathan McCone ◽

Mitchell N. Davis ◽

Lorenzo Rossaro ◽

Eugene Schiff ◽

...

Keyword(s):

Clinical Trials ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Safety Profile ◽

Phase 2 ◽

Genotype 1 ◽

Combined Analysis ◽

Peginterferon Alfa

Download Full-text

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63650-1 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-983

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1 ◽

Life Conditions ◽

Peginterferon Alfa

Download Full-text

S1006 Efficacy and Safety of Peginterferon Alfa-2a or −2b Plus Ribavirin in the Routine Daily Treatment of Chronic Hepatitis C Patients in Germany: the Practice Study

Gastroenterology ◽

10.1016/s0016-5085(08)63611-2 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-773

Author(s):

Thomas Witthoeft ◽

Dietrich Hueppe ◽

Christine John ◽

Joerg Goelz ◽

Ulrike Meyer ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Daily Treatment ◽

Efficacy And Safety ◽

Practice Study ◽

Peginterferon Alfa ◽

Chronic Hepatitis C Patients

Download Full-text

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

Gastroenterology ◽

10.1016/s0016-5085(13)63639-2 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-980 ◽

Cited By ~ 1

Author(s):

Gero Moog ◽

Stefan Mauss ◽

Dietrich Hueppe ◽

Ulrich Spengler ◽

Eckart Schott ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Genotype 1 ◽

Life Conditions ◽

Peginterferon Alfa

Download Full-text

782 CHRONIC HEPATITIS C GENOTYPE 4: EFFICACY AND SAFETY OF THE TREATMENT WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRIN

Journal of Hepatology ◽

10.1016/s0168-8278(08)60784-9 ◽

2008 ◽

Vol 48 ◽

pp. S292

Author(s):

M. Diago ◽

J. Boadas ◽

R. Planas ◽

R. Sola ◽

J.A. del Olmo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Genotype 4 ◽

Peginterferon Alfa

Download Full-text